Last $0.0012 USD
Change Today 0.00 / 0.00%
Volume 0.0
CHBO On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 07/30/14 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

173 Yugu Lu

Zhongtian DaSha 16-L

Hangzhou, 310007

China

Phone:

Fax:

China Biopharma, Inc., a development stage company, engages in the development and marketing of human vaccines and other pharmaceutical products in the People's Republic of China. Products and Services The company’s products primarily consist of vaccines for preventing and treating various diseases and illnesses in humans and other pharmaceutical products. The company, through its subsidiary, Hainan CITIC Bio-Pharmaceutical Development Co., Ltd. (HCBD), utilizes its distribution platforms and logistics to distribute other medical products and to provide logistic services for other bio-pharmaceutical companies. It has an agreement to distribute Serrapeptase tablets manufactured by Takeda Pharmaceutical Company, Ltd. (Takeda), a pharmaceutical company in Japan. Subsidiaries The company has two operational segments. One segment, consisting of China BioPharma Limited (CBL) and its subsidiaries provides bio-pharmaceutical products. The other segment, which consists of China Quantum Communication Limited (CQCL) and its subsidiary, engages in the business of providing telecommunications services and developing related technology. China Biopharma Limited: CBL manages the operations of all the company’s bio-pharmaceutical business in China. Zhejiang Tianyuan Biotech Co., Ltd.: Zhejiang Tianyuan Biotech Co., Ltd (ZTBC) is a Sino-U.S. joint venture between CBL and Zhejiang Tianyuan. The company owns 65% of ZTBC and Zhejiang Tianyuan owns 35%. Hainan CITIC Bio-pharmaceutical Development Co., Ltd.: ZTBC is the owner of 70% of the equity interest in Hainan CITIC Bio-pharmaceutical Development Co., Ltd (HCBD). HCBD is a nationwide bio-pharmaceutical distributor in China. China Quantum Communication Limited: China Quantum Communication Limited is a Cayman Islands company and a wholly-owned subsidiary of the company. CQCL holds all of the company’s telecommunications business interests and owns all the intellectual property of mobile VoIP technology. Guang Tong Wang Luo Ke Ji (China) Co., Ltd.: Guang Tong Wang Luo Ke Ji (China) Co., Ltd. (also known as Quantum Communication (China) Co., Ltd (QCCN)) is a wholly-owned subsidiary of CQCL. Suppliers The company’s supplier includes Zhongxin Pharmaceutical Co., Ltd. Customers The company distributes its products directly or indirectly to local hospitals, clinics, pension fund health programs, and CDCs in China. In 2008, the company’s major customer was Beijing Ke Yuan Xin Hai Pharmaceutical Co., Ltd. Competition The company competes with drug companies, such as Merck, GlaxoSmithKline, Sanofi Pasteur, and Novartis. History China Biopharma, Inc. was founded in 1997.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CHBO:US $0.00 USD 0.00

CHBO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CHBO.
View Industry Companies
 

Industry Analysis

CHBO

Industry Average

Valuation CHBO Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.0x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHINA BIOPHARMA INC, please visit www.chinabiopharma.com.cn. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.